Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection

Hyaluronic acid dermal fillers are a very popular choice for patients wanting to undergo non-invasive facial rejuvenation. Its prevalence is predicted to continue to rise. We report a case of delayed angioedema and associated urticaria to hyaluronic acid dermal fillers post COVID-19 infection. To ou...

Descripción completa

Detalles Bibliográficos
Autor principal: Virdi, Gurnam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131708/
https://www.ncbi.nlm.nih.gov/pubmed/35637833
http://dx.doi.org/10.7759/cureus.24461
_version_ 1784713229848543232
author Virdi, Gurnam
author_facet Virdi, Gurnam
author_sort Virdi, Gurnam
collection PubMed
description Hyaluronic acid dermal fillers are a very popular choice for patients wanting to undergo non-invasive facial rejuvenation. Its prevalence is predicted to continue to rise. We report a case of delayed angioedema and associated urticaria to hyaluronic acid dermal fillers post COVID-19 infection. To our knowledge, this is an unusual case of hypersensitivity reaction of eight-month latency. Although the aetiology warrants further research, the author suggests utilisation of a four-week time window between dermal filler injections and COVID-19 vaccination.
format Online
Article
Text
id pubmed-9131708
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-91317082022-05-29 Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection Virdi, Gurnam Cureus Allergy/Immunology Hyaluronic acid dermal fillers are a very popular choice for patients wanting to undergo non-invasive facial rejuvenation. Its prevalence is predicted to continue to rise. We report a case of delayed angioedema and associated urticaria to hyaluronic acid dermal fillers post COVID-19 infection. To our knowledge, this is an unusual case of hypersensitivity reaction of eight-month latency. Although the aetiology warrants further research, the author suggests utilisation of a four-week time window between dermal filler injections and COVID-19 vaccination. Cureus 2022-04-25 /pmc/articles/PMC9131708/ /pubmed/35637833 http://dx.doi.org/10.7759/cureus.24461 Text en Copyright © 2022, Virdi et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Allergy/Immunology
Virdi, Gurnam
Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection
title Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection
title_full Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection
title_fullStr Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection
title_full_unstemmed Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection
title_short Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection
title_sort dermal fillers and covid-19: angioedema with urticaria in a patient post covid-19 infection
topic Allergy/Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131708/
https://www.ncbi.nlm.nih.gov/pubmed/35637833
http://dx.doi.org/10.7759/cureus.24461
work_keys_str_mv AT virdigurnam dermalfillersandcovid19angioedemawithurticariainapatientpostcovid19infection

Ejemplares similares